Evidence map›Paper›PMID 19005416›Full record

ArticleTransplantation2008

Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury.

Karen Keslar, E Rene Rodriguez, Carmela D Tan, Randall C Starling, Peter S Heeger

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Sterile inflammation in thoracic transplantation.Cellular and molecular life sciences : CMLS · 2021
    Review
  4. C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  5. Review
  6. Article
  7. Article
  8. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2016
    Observational
  9. Review
  10. Molecules Great and Small: The Complement System.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Review
  11. Complement as a multifaceted modulator of kidney transplant injury.The Journal of clinical investigation · 2014
    Review
  12. Complement regulation of T-cell alloimmunity.Seminars in nephrology · 2013
    Review
  13. Complement regulation of T cell immunity.Immunologic research · 2012
    Review
  14. Review
  15. Complement regulation of T-cell alloimmunity.Current opinion in organ transplantation · 2011
    Review
  16. Article
  17. Innate immunity and cardiac allograft rejection.Kidney international. Supplement · 2010
    Review
  18. Evolving paradigms that determine the fate of an allograft.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2010
    Review
  19. Innate immunity in heart transplantation.Current opinion in organ transplantation · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Karen KeslarDepartment of Immunology, The Cleveland Clinic, Cleveland, OH, USA.
E Rene Rodriguez
Carmela D Tan
Randall C Starling
Peter S Heeger
Cleveland Clinic · US

Funding

Noninvasive Markers and Transplant Outcome in HumansU01AI063594 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HEEGER, PETER SCOTT · 2004 to 2022
$66.5M
GRAFT REJECTION AND DIRECT VERSUS INDIRECT RECOGNITIONR01AI043578 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HEEGER, PETER SCOTT · 1998 to 2013
$3.8M
NIAID NIH HHS R01 AI043578NIAID NIH HHS U01 AI063594NIAID NIH HHS U01 AI63594
6 · The paper itself

Abstract

Complement activation contributes to antibody-mediated allograft rejection, but increasing evidence also implicates complement proteins produced locally within the graft, in part by infiltrating mononuclear cells, as important mediators of tissue injury. To test this concept in transplant recipients, we evaluated complement, complement regulator, and T cell/proinflammatory marker gene expression by quantitative real-time polymerase chain reaction in 71 archived heart transplant biopsies and correlated the results with the histologic grade of rejection. Significantly more transcripts encoding alternative pathway components factor B, C3 and properdin, and C3a receptor and C5a receptor were detected in grade 3 versus grade 0 or 1 biopsies. The grade 3 rejections also contained significantly higher amounts of CD3, interferon gamma, perforin, and granzyme B genes. In addition to providing supportive evidence for a pathogenic role of graft-derived complement in human heart transplant injury, these correlations suggest that molecular profiling of complement gene expression could be useful in the diagnosis of human allograft rejection.

Indexed as

Severity of Illness IndexBiopsyCD3 ComplexComplement C3Complement Factor BComplement System ProteinsGene ExpressionGraft RejectionGranzymesHeart TransplantationHumansInterferon-gammaMyocardiumPerforinProperdinReceptor, Anaphylatoxin C5aC5AR1 protein, humanCD3 ComplexComplement C3complement C3a receptorComplement Factor BComplement System ProteinsGranzymesInterferon-gammaPerforinProperdinReceptor, Anaphylatoxin C5aReceptors, Complement

Identifiers

PMID19005416
PMCPMC2646139
OpenAlexW2018758996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.